P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

• F. L. Locke,
• J. Chou,
• S. Vardhanabhuti,
• R. Perbost,
• P. Dreger,
• B. T. Hill,
• C. Lee,
• P. L. Zinzani,
• N. Kröger,
• A. López-Guillermo,
• H. Greinix,
• W. Zhang,
• G. Tiwari,
• C. To,
• P. Cheng,
• A. Bot,
• R. Shen,
• S. Filosto,
• J. Galon

Affiliations

F. L. Locke

1 Moffitt Cancer Center, Tampa, FL

J. Chou

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

S. Vardhanabhuti

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

R. Perbost

3 HalioDx, Marseille, France

P. Dreger

4 Heidelberg University Hospital, Heidelberg, Germany

B. T. Hill

5 Cleveland Clinic Foundation, Cleveland, OH

C. Lee

6 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States of America

P. L. Zinzani

7 University of Bologna, Bologna, Italy

N. Kröger

8 University Medical Center Hamburg, Hamburg, Germany

A. López-Guillermo

9 Department of Hematology, Hospital Clinic, Barcelona, Spain

H. Greinix

10 Division of Hematology Medical University Graz, Graz, Austria

W. Zhang

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

G. Tiwari

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

C. To

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

P. Cheng

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

A. Bot

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

R. Shen

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

S. Filosto

2 Kite, a Gilead Company, Santa Monica, CA, United States of America

J. Galon

11 INSERM, Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Equipe Labellisée Ligue Contre le Cancer, Laboratory of Integrative Cancer Immunology, F-75006, Paris, France